HNO International, Inc.
HNOI · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.72 | 4.56 | -0.26 | 16.03 |
| FCF Yield | -0.92% | -0.55% | -0.61% | -0.02% |
| EV / EBITDA | -117.60 | -295.67 | -173.75 | 0.00 |
| Quality | ||||
| ROIC | -2,190.06% | -110.45% | -1,061.08% | 6,880.43% |
| Gross Margin | 13.04% | 50.15% | 19.62% | 0.00% |
| Cash Conversion Ratio | 0.81 | 0.99 | 1.05 | 0.28 |
| Growth | ||||
| Revenue 3-Year CAGR | -50.25% | – | – | – |
| Free Cash Flow Growth | 2.13% | -99.00% | -2,862.86% | 14.01% |
| Safety | ||||
| Net Debt / EBITDA | -0.73 | -0.83 | -1.10 | 0.00 |
| Interest Coverage | -80.08 | -53.38 | -71.75 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -0.49 | 0.00 |
| Cash Conversion Cycle | -13,660.68 | -52.09 | -743.29 | 0.00 |